Biotech · Private company
AgelessRx
Track this companyFree. Adds AgelessRx to your Dealase workspace and tells you when its record changes.
Clinical trials102 recruiting or active
Pipeline programs18From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline18
- GSHPhase 3 · Healthspan ImprovementClinicalTrials.gov · fetched Nov 12, 2026
- Infinite SupplementPhase 3 · Healthspan ImprovementClinicalTrials.gov · fetched Nov 12, 2026
- MetforminPhase 3 · Healthspan ImprovementClinicalTrials.gov · fetched Nov 12, 2026
- MetforminPhase 3 · LongevityClinicalTrials.gov · fetched Nov 12, 2026
- NAD+Phase 3 · Healthspan ImprovementClinicalTrials.gov · fetched Nov 12, 2026
- NaltrexonePhase 3 · Healthspan ImprovementClinicalTrials.gov · fetched Nov 12, 2026
- NaltrexonePhase 3 · LongevityClinicalTrials.gov · fetched Nov 12, 2026
- RapamycinPhase 3 · Healthspan ImprovementClinicalTrials.gov · fetched Nov 12, 2026
- RapamycinPhase 3 · LongevityClinicalTrials.gov · fetched Nov 12, 2026
- Vitamin CPhase 3 · LongevityClinicalTrials.gov · fetched Nov 12, 2026
- MetforminPhase 2 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- NAD+Phase 2 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- NaltrexonePhase 2 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- RapamycinPhase 2 · AgingClinicalTrials.gov · fetched Nov 12, 2026
- GLP-1Phase 1 · LongevityClinicalTrials.gov · fetched Nov 12, 2026
- Acarbose Tablets 50mgToleranceClinicalTrials.gov · fetched Nov 12, 2026
- Invokana PillHealthy AgingClinicalTrials.gov · fetched Nov 12, 2026
- low-dose naltrexoneAgingClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials10
- Combination Gerotherapeutic Interventions for Healthspan ImprovementPHASE3 · COMPLETED · started Jul 23, 2025ClinicalTrials.gov NCT07475546 · fetched Nov 12, 2026
- Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-CessationPHASE2_PHASE3 · RECRUITING · started Dec 17, 2024ClinicalTrials.gov NCT07092618 · fetched Nov 12, 2026
- Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity MeasuresEARLY_PHASE1 · ENROLLING_BY_INVITATION · started Nov 1, 2024ClinicalTrials.gov NCT07092605 · fetched Nov 12, 2026
- The Efficacy and Tolerability of Canagliflozin in Healthy IndividualPHASE4 · COMPLETED · started Feb 12, 2024ClinicalTrials.gov NCT06301529 · fetched Nov 12, 2026
- The Bioavailability of Compounded and Generic Rapamycin in Normative Aging IndividualsCOMPLETED · started Apr 25, 2023ClinicalTrials.gov NCT06550271 · fetched Nov 12, 2026
- The Efficacy and Tolerability of Acarbose in Healthy IndividualsPHASE4 · COMPLETED · started Aug 10, 2022ClinicalTrials.gov NCT05542849 · fetched Nov 12, 2026
- The Effects of Low Dose Naltrexone (LDN) on Diseases of AgingWITHDRAWN · started Mar 14, 2022ClinicalTrials.gov NCT05307627 · fetched Nov 12, 2026
- Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19PHASE2 · WITHDRAWN · started Feb 1, 2021ClinicalTrials.gov NCT04604678 · fetched Nov 12, 2026
- Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 SyndromePHASE2 · COMPLETED · started Jan 28, 2021ClinicalTrials.gov NCT04604704 · fetched Nov 12, 2026
- Participatory Evaluation (of) Aging (With) Rapamycin (for) Longevity StudyPHASE2 · COMPLETED · started Jan 1, 2020ClinicalTrials.gov NCT04488601 · fetched Nov 12, 2026